Artivion | CRY - 应收帐款人

金融业

USD

USD 883.16M

现金及等价物

USD 55.76M

USD 42.85M

USD 357.52M

USD 92.7M

USD 317.78M

USD 4.79M

USD 22.72M

1.5K

EPS每股收益

USD -0.02

股本和储备

USD 450.47M

USD 73.14M

债务利息支出

USD 5.53M

USD -0.05

USD 215.35M

USD 975.8M

USD 2.42M

USD 111.2M

USD 4.79M

普通股股本

USD 47.84M

212.38

USD 11.4M

USD 115.99M

销售和管理费用

USD 55.75M

USD 98M

贸易债权人

USD 18.34M

应收帐款人

USD 103.68M

	应收帐款人	更改		日
Abbott	USD 10.57B		171M	2025-12
Accuray	USD 91.79M		7.07M	2024-09
AngioDynamics	USD 44.43M		1.79M	2025-09
Artivion	USD 103.68M		6.31M	2025-12
AtriCure	USD 71.31M		4.66M	2026-03
Baxter International	USD 1.7B		310M	2026-03
Becton, Dickinson and Co.	USD 2.2B		303M	2026-03
Boston Scientific	USD 2.93B		98M	2025-12
Edwards Lifesciences	USD 912.1M		19.3M	2025-12
Inogen	USD 37.09M		4.11M	2024-06
Integra LifeSciences	USD 264.41M		14.44M	2026-03
J&J	USD 21.33B		3.72B	2025-12
Mesa Laboratories	USD 40.23M		4.66M	2024-09
Orthofix International	USD 135.75M		4.94M	2025-12
Pfizer	USD 16.17B		332M	2026-03
ResMed	USD 998.84M		13.2M	2026-03
Stryker	USD 3.57B		468M	2026-03
Tandem Diabetes Care	USD 165.49M		39.55M	2025-12
Teleflex	USD 365.53M		19.94M	2026-03
Terumo	JPY 217.57B		2.28B	2026-03
Trinity Biotech	USD 10.28M		4.74M	2025-12